Search

like UP, that is showing signs of emerging epidemic. These emerging districts and sub-epidemics are related to population migration, and lack of focus on preventive measures. Kanpur is one of the industrial centers of UPwith considerable migrant population. The low awareness regarding HIV transmission noted in the study (0e5.6%) among road-side barbers is of special concern andmay point to lack of focus on IEC and other preventive strategies in this geographical area. It is important to bring this to the notice of the state AIDS Control Organization and NACO. Though the results of the study may not be of major concern with regard to HIV epidemic in India, it has implications on other blood borne infections. There is greater need for effective strategies to control transmission of HBV and HCV in the community. Vaccination and ensuring improved hygienic practices are the best answers to this problem. I am sure that the information generated in the article will help us to refocus our efforts in strengthening the strategies to control blood borne infections in the country.

The influence of the mixing parameters on the synthesis of Al–SiCp reinforced metal matrix composites (MMCs) by the stir casting technique is investigated through a water model. The effects of some important mixing parameters such as impeller blade angle, rotating speed, direction of impeller rotation and effect of baffles are investigated and optimized. The results have shown that the axial concentration variation of natural graphite during stirring in the presence of four vertical baffles is 1.0 wt% against in the absence of baffles it is increased to 2.3 wt%. The variations observed in natural graphite concentration in water during mixing are in close agreement with the earlier modeling and limited experimental studies reported on the real molten aluminum–SiC system. Semi-empirical correlations arrived at between the dimensionless numbers for stirred water – natural graphite slurries are Po = Re−0.0545 Fr−1.099 and Po = Re−0.0219 Fr−1.0382 for clockwise and counter clockwise rotation respectively.

Background WHO-defined pneumonias, treated with antibiotics, are responsible for a significant proportion of childhood morbidity and mortality in the developing countries. Since substantial proportion pneumonias have a viral etiology, where children are more likely to present with wheeze, there is a concern that currently antibiotics are being over-prescribed for it. Hence the current trial was conducted with the objective to show the therapeutic equivalence of two treatments (placebo and amoxycillin) for children presenting with non-severe pneumonia with wheeze, who have persistent fast breathing after nebulisation with salbutamol, and have normal chest radiograph. Methodology This multi-centric, randomised placebo controlled double blind clinical trial intended to investigate equivalent efficacy of placebo and amoxicillin and was conducted in ambulatory care settings in eight government hospitals in India. Participants were children aged 2–59 months of age, who received either oral amoxycillin (31–54 mg/Kg/day, in three divided doses for three days) or placebo, and standard bronchodilator therapy. Primary outcome was clinical failure on or before day- 4. Principal Findings We randomized 836 cases in placebo and 835 in amoxycillin group. Clinical failures occurred in 201 (24.0%) on placebo and 166 (19.9%) on amoxycillin (risk difference 4.2% in favour of antibiotic, 95% CI: 0.2 to 8.1). Adherence for both placebo and amoxycillin was >96% and 98.9% subjects were followed up on day- 4. Clinical failure was associated with (i) placebo treatment (adjusted OR = 1.28, 95% CI: 1.01 to1.62), (ii) excess respiratory rate of >10 breaths per minute (adjusted OR = 1.51, 95% CI: 1.19, 1.92), (iii) vomiting at enrolment (adjusted OR = 1.49, 95% CI: 1.13, 1.96), (iv) history of use of broncho-dilators (adjusted OR = 1.71, 95% CI: 1.30, 2.24) and (v) non-adherence (adjusted OR = 8.06, 95% CI: 4.36, 14.92). Conclusions Treating children with non-severe pneumonia and wheeze with a placebo is not equivalent to treatment with oral amoxycillin. Trial Registration ClinicalTrials.gov NCT00407394